Efficacy and safety comparison of bevacizumab and immune checkpoint inhibitors in non-small cell lung cancer patients with brain metastases

Efficacy and safety comparison of bevacizumab and immune checkpoint inhibitors in non-small cell lung cancer patients with brain metastases

ZHANG Chi, WANG Liye, GONG Shuai, PANG Lina, ZHANG Shengli, ZHANG Xiaoke, LI Mingyu, YANG Yang, HE Wei

PDF(5625 KB)

Tumor website：www.tumorsci.org E-mail Alert

PDF(5625 KB)

Tumor ›› 0 DOI: 10.3781/j.issn.1000-7431.2026.2505-0303

Original Research

Efficacy and safety comparison of bevacizumab and immune checkpoint inhibitors in non-small cell lung cancer patients with brain metastases

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 0 https://doi.org/10.3781/j.issn.1000-7431.2026.2505-0303

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(5625 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉